The global cell & gene therapy bioanalytical testing services market size is expected to reach USD 828.7 million by 2030, growing at a CAGR of 7.3% from 2024 to 2030. Increasing R&D activities related to cell and gene therapy, growth in investments by public organizations for cell and gene therapy research and high potential of gene and cell therapy in treating rare diseases are the key factors driving the growth of the market. ![Global Cell & Gene Therapy Bioanalytical Testing Services Market]( "Global Cell & Gene Therapy Bioanalytical Testing Services Market")
Cell and gene therapies have popularly been adopted in the treatment of cancer, autoimmune diseases, and rare diseases. These therapies have shown a significant improvement in patients' clinical conditions, owing to which a significant number of cell and gene therapy drug candidates are in the pipeline. For instance, according to the American Society of Cell and Gene Therapy, over 2,053 gene therapies and 827 non-genetically modified cell therapies were in the pipeline as of January 2023. High number of cell and gene therapy drug candidates in pipeline is promoting the demand for bioanalytical testing services.
Public and private organizations are actively investing in cell and gene therapy-based research. For instance, in April 2023, the California Institute for Regenerative Medicine invested USD 89.0 million in stem cell and gene therapy research. This funding was planned for the development of therapy in the treatment of persistent corneal epithelial defects. Similar fundings in the future is expected to boost the demand for bioanalytical testing services in the forecasted period.
The COVID-19 pandemic had a negative impact on the market for cell & gene therapy bioanalytical testing services. The majority of the cell and gene therapy-based trials were postponed in the pandemic. However, in the post COVID-19 era, the scenario is changing, and many trials are resumed. This is expected to support market growth in the post-COVID-19 period.
Cell and gene therapies have popularly been adopted in the treatment of cancer, autoimmune diseases, and rare diseases. These therapies have shown a significant improvement in patients' clinical conditions, owing to which a significant number of cell and gene therapy drug candidates are in the pipeline. For instance, according to the American Society of Cell and Gene Therapy, over 2,053 gene therapies and 827 non-genetically modified cell therapies were in the pipeline as of January 2023. High number of cell and gene therapy drug candidates in pipeline is promoting the demand for bioanalytical testing services.
Public and private organizations are actively investing in cell and gene therapy-based research. For instance, in April 2023, the California Institute for Regenerative Medicine invested USD 89.0 million in stem cell and gene therapy research. This funding was planned for the development of therapy in the treatment of persistent corneal epithelial defects. Similar fundings in the future is expected to boost the demand for bioanalytical testing services in the forecasted period.
The COVID-19 pandemic had a negative impact on the market for cell & gene therapy bioanalytical testing services. The majority of the cell and gene therapy-based trials were postponed in the pandemic. However, in the post COVID-19 era, the scenario is changing, and many trials are resumed. This is expected to support market growth in the post-COVID-19 period.
Cell & Gene Therapy Bioanalytical Testing Services Market Report Highlights
- Based on test type, the bioavailability & bioequivalence studies segment accounted for the largest revenue share of around 35.4% in 2023. Bioavailability & bioequivalence studies primarily focus on the R&D of pharmaceutical & biotechnological products such as cell and gene therapies. In cell & gene therapies, bioavailability refers to the proportion of the administered dose of a therapeutic agent that reaches the systemic circulation.
- Based on product type, cell therapy accounted for the largest revenue share of 42.1% in 2023. Cell therapies have great potential in treating autoimmune diseases, cancers, and other conditions. This is improving the clinical research in cell therapy, thus boosting the demand for bioanalytical services for cell therapy.
- Based on the stage of development by product type, the non-clinical segment held a share of 66.2% in 2023. Bioanalytical testing for non-clinical stage is essential for obtaining IND approval. The high demand among researchers for transitioning the therapy into the clinical stage is supporting the market growth of the segment.
- Based on indication, the oncology segment held the maximum revenue share of 49.0% in 2023. The high potential of gene and cell therapy to treat cancer cells effectively is the prime reason for the segment market growth.
- Asia Pacific is anticipated to witness the highest CAGR of 7.7% during the forecast time frame. Funding for cell and gene therapy-based research by public organizations and the low cost associated with outsourcing bioanalytical services in the region is supporting the segment market growth.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Product Type
1.2.3. Stage of Development by Product Type
1.2.4. Indication
1.2.5. Regional Scope
1.2.6. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Approach 1: Commodity Flow Approach
1.7.3. Volume Price Analysis (Model 2)
1.7.4. Approach 2: Volume Price Analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Product Type
1.2.3. Stage of Development by Product Type
1.2.4. Indication
1.2.5. Regional Scope
1.2.6. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Approach 1: Commodity Flow Approach
1.7.3. Volume Price Analysis (Model 2)
1.7.4. Approach 2: Volume Price Analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type
2.2.2. Product Type
2.2.3. Stage of Development by Product Type
2.2.4. Indication
2.2.5. Regional Scope
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Test Type
2.2.2. Product Type
2.2.3. Stage of Development by Product Type
2.2.4. Indication
2.2.5. Regional Scope
2.3. Competitive Insights
Chapter 3. Cell & Gene Therapy Bioanalytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Significant Number of Cell & Gene Therapy Drug Candidates Under Clinical Trials
3.2.1.2. High Public and Private Investments Across Research and Development of Novel Cell & Gene Products to Augment Market Growth
3.2.1.3. High Focus of Biopharmaceutical Companies to Reduce Operational Costs Promoting the Demand for Outsourcing
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of Alternative Treatment Options at Lower Cost
3.2.2.2. Quality Issues Associated with Outsourcing
3.3. Cell & Gene Therapy Bioanalytical Testing Services Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Significant Number of Cell & Gene Therapy Drug Candidates Under Clinical Trials
3.2.1.2. High Public and Private Investments Across Research and Development of Novel Cell & Gene Products to Augment Market Growth
3.2.1.3. High Focus of Biopharmaceutical Companies to Reduce Operational Costs Promoting the Demand for Outsourcing
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of Alternative Treatment Options at Lower Cost
3.2.2.2. Quality Issues Associated with Outsourcing
3.3. Cell & Gene Therapy Bioanalytical Testing Services Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
Chapter 4. Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis
4.1. Test Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Hematology Testing Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Bioavailability & Bioequivalence Studies
4.4.1.1. Bioavailability & Bioequivalence Market, 2018 to 2030 (USD Million)
4.4.2. Pharmacokinetics
4.4.2.1. Pharmacokinetics Market, 2018 to 2030 (USD Million)
4.4.3. Pharmacodynamics
4.4.3.1. Pharmacodynamics Market, 2018 to 2030 (USD Million)
4.4.4. Other Test Types
4.4.4.1. Other Test Types Market, 2018 to 2030 (USD Million)
4.2. Segment Dashboard
4.3. Global Hematology Testing Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Bioavailability & Bioequivalence Studies
4.4.1.1. Bioavailability & Bioequivalence Market, 2018 to 2030 (USD Million)
4.4.2. Pharmacokinetics
4.4.2.1. Pharmacokinetics Market, 2018 to 2030 (USD Million)
4.4.3. Pharmacodynamics
4.4.3.1. Pharmacodynamics Market, 2018 to 2030 (USD Million)
4.4.4. Other Test Types
4.4.4.1. Other Test Types Market, 2018 to 2030 (USD Million)
Chapter 5. Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Estimates & Trend Analysis
5.1. Product Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market by Product Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Gene Therapy
5.4.1.1. Gene Therapy Market, 2018 to 2030 (USD Million)
5.4.1.2. Ex-vivo
5.4.1.3. Ex-vivo Market, 2018 to 2030 (USD Million)
5.4.1.4. In-vivo
5.4.1.5. In-vivo Market, 2018 to 2030 (USD Million)
5.4.2. Gene-Modified Cell Therapy
5.4.2.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
5.4.2.2. CAR T-cell Therapies
5.4.2.3. CAR T-Cell Therapies Market, 2018 to 2030 (USD Million)
5.4.2.4. CAR-NK Cell Therapy
5.4.2.5. CAR-NK Cell Therapy Market, 2018 to 2030 (USD Million)
5.4.2.6. TCR-T Cell Therapy
5.4.2.7. TCR-T Cell Therapy Market, 2018 to 2030 (USD Million)
5.4.2.8. Others
5.4.2.9. Others Market, 2018 to 2030 (USD Million)
5.4.3. Cell Therapy
5.4.3.1. Cell Therapy Market, 2018 to 2030 (USD Million)
5.2. Segment Dashboard
5.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market by Product Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Gene Therapy
5.4.1.1. Gene Therapy Market, 2018 to 2030 (USD Million)
5.4.1.2. Ex-vivo
5.4.1.3. Ex-vivo Market, 2018 to 2030 (USD Million)
5.4.1.4. In-vivo
5.4.1.5. In-vivo Market, 2018 to 2030 (USD Million)
5.4.2. Gene-Modified Cell Therapy
5.4.2.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
5.4.2.2. CAR T-cell Therapies
5.4.2.3. CAR T-Cell Therapies Market, 2018 to 2030 (USD Million)
5.4.2.4. CAR-NK Cell Therapy
5.4.2.5. CAR-NK Cell Therapy Market, 2018 to 2030 (USD Million)
5.4.2.6. TCR-T Cell Therapy
5.4.2.7. TCR-T Cell Therapy Market, 2018 to 2030 (USD Million)
5.4.2.8. Others
5.4.2.9. Others Market, 2018 to 2030 (USD Million)
5.4.3. Cell Therapy
5.4.3.1. Cell Therapy Market, 2018 to 2030 (USD Million)
Chapter 6. Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type Estimates & Trend Analysis
6.1. Stage of Development by Product Type Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Stage of Development by Product Type Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Non-Clinical
6.4.1.1. Non-Clinical Market, 2018 to 2030 (USD Million)
6.4.1.2. Gene Therapy
6.4.1.2.1. Gene Therapy Market, 2018 to 2030 (USD Million)
6.4.1.3. Gene-Modified Cell Therapy
6.4.1.3.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
6.4.1.4. Cell Therapy
6.4.1.4.1. Cell Therapy Market, 2018 to 2030 (USD Million)
6.4.2. Clinical
6.4.2.1. Clinical Market, 2018 to 2030 (USD Million)
6.4.2.2. Gene Therapy
6.4.2.2.1. Gene Therapy Market, 2018 to 2030 (USD Million)
6.4.2.3. Gene-Modified Cell Therapy
6.4.2.3.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
6.4.2.4. Cell Therapy
6.4.2.4.1. Cell Therapy Market, 2018 to 2030 (USD Million)
6.2. Segment Dashboard
6.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Stage of Development by Product Type Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Non-Clinical
6.4.1.1. Non-Clinical Market, 2018 to 2030 (USD Million)
6.4.1.2. Gene Therapy
6.4.1.2.1. Gene Therapy Market, 2018 to 2030 (USD Million)
6.4.1.3. Gene-Modified Cell Therapy
6.4.1.3.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
6.4.1.4. Cell Therapy
6.4.1.4.1. Cell Therapy Market, 2018 to 2030 (USD Million)
6.4.2. Clinical
6.4.2.1. Clinical Market, 2018 to 2030 (USD Million)
6.4.2.2. Gene Therapy
6.4.2.2.1. Gene Therapy Market, 2018 to 2030 (USD Million)
6.4.2.3. Gene-Modified Cell Therapy
6.4.2.3.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
6.4.2.4. Cell Therapy
6.4.2.4.1. Cell Therapy Market, 2018 to 2030 (USD Million)
Chapter 7. Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Estimates & Trend Analysis
7.1. Stage of Development by Indication Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Stage of Development by Indication Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Oncology
7.4.1.1. Oncology Market 2018 to 2030 (USD Million)
7.4.2. Infectious Diseases
7.4.2.1. Infectious Market 2018 to 2030 (USD Million)
7.4.3. Neurological Disorders
7.4.3.1. Neurological Disorders Market 2018 to 2030 (USD Million)
7.4.4. Rare Diseases
7.4.4.1. Rare Diseases Market 2018 to 2030 (USD Million)
7.4.5. Others
7.4.5.1. Others Market 2018 to 2030 (USD Million)
7.2. Segment Dashboard
7.3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Stage of Development by Indication Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Oncology
7.4.1.1. Oncology Market 2018 to 2030 (USD Million)
7.4.2. Infectious Diseases
7.4.2.1. Infectious Market 2018 to 2030 (USD Million)
7.4.3. Neurological Disorders
7.4.3.1. Neurological Disorders Market 2018 to 2030 (USD Million)
7.4.4. Rare Diseases
7.4.4.1. Rare Diseases Market 2018 to 2030 (USD Million)
7.4.5. Others
7.4.5.1. Others Market 2018 to 2030 (USD Million)
Chapter 8. Cell & Gene Therapy Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
8.5.2. U.S.
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. U.S. Market Estimates and Forecasts, 2018-2030
8.5.3. Canada
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Canada Market Estimates and Forecasts, 2018-2030
8.6. Europe
8.6.1. UK
8.6.1.1. Key Country Dynamics
8.6.1.2. Competitive Scenario
8.6.1.3. Regulatory Framework
8.6.1.4. UK Market Estimates and Forecasts, 2018-2030
8.6.2. Germany
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Germany Market Estimates and Forecasts, 2018-2030
8.6.3. France
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. France Market Estimates and Forecasts, 2018-2030
8.6.4. Italy
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Italy Market Estimates and Forecasts, 2018-2030
8.6.5. Spain
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Spain Market Estimates and Forecasts, 2018-2030
8.6.6. Denmark
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Denmark Market Estimates and Forecasts, 2018-2030
8.6.7. Sweden
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Sweden Market Estimates and Forecasts, 2018-2030
8.6.8. Norway
8.6.8.1. Key Country Dynamics
8.6.8.2. Competitive Scenario
8.6.8.3. Regulatory Framework
8.6.8.4. Norway Market Estimates and Forecasts, 2018-2030
8.7. Asia-Pacific
8.7.1. Japan
8.7.1.1. Key Country Dynamics
8.7.1.2. Competitive Scenario
8.7.1.3. Regulatory Framework
8.7.1.4. Japan Market Estimates and Forecasts, 2018-2030
8.7.2. India
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. India Market Estimates and Forecasts, 2018-2030
8.7.3. China
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. China Market Estimates and Forecasts, 2018-2030
8.7.4. South Korea
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. South Korea Market Estimates and Forecasts, 2018-2030
8.7.5. Australia
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Australia Market Estimates and Forecasts, 2018-2030
8.7.6. Thailand
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Thailand Market Estimates and Forecasts, 2018-2030
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key Country Dynamics
8.8.1.2. Competitive Scenario
8.8.1.3. Regulatory Framework
8.8.1.4. Brazil Market Estimates and Forecasts, 2018-2030
8.8.2. Mexico
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Mexico Market Estimates and Forecasts, 2018-2030
8.8.3. Argentina
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Argentina Market Estimates and Forecasts, 2018-2030
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key Country Dynamics
8.9.1.2. Competitive Scenario
8.9.1.3. Regulatory Framework
8.9.1.4. South Africa Market Estimates and Forecasts, 2018-2030
8.9.2. Saudi Arabia
8.9.2.1. Key Country Dynamics
8.9.2.2. Competitive Scenario
8.9.2.3. Regulatory Framework
8.9.2.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030
8.9.3. UAE
8.9.3.1. Key Country Dynamics
8.9.3.2. Competitive Scenario
8.9.3.3. Regulatory Framework
8.9.3.4. UAE Market Estimates and Forecasts, 2018-2030
8.9.4. Kuwait
8.9.4.1. Key Country Dynamics
8.9.4.2. Competitive Scenario
8.9.4.3. Regulatory Framework
8.9.4.4. Kuwait Market Estimates and Forecasts, 2018-2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
8.5.2. U.S.
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. U.S. Market Estimates and Forecasts, 2018-2030
8.5.3. Canada
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Canada Market Estimates and Forecasts, 2018-2030
8.6. Europe
8.6.1. UK
8.6.1.1. Key Country Dynamics
8.6.1.2. Competitive Scenario
8.6.1.3. Regulatory Framework
8.6.1.4. UK Market Estimates and Forecasts, 2018-2030
8.6.2. Germany
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Germany Market Estimates and Forecasts, 2018-2030
8.6.3. France
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. France Market Estimates and Forecasts, 2018-2030
8.6.4. Italy
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Italy Market Estimates and Forecasts, 2018-2030
8.6.5. Spain
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Spain Market Estimates and Forecasts, 2018-2030
8.6.6. Denmark
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Denmark Market Estimates and Forecasts, 2018-2030
8.6.7. Sweden
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Sweden Market Estimates and Forecasts, 2018-2030
8.6.8. Norway
8.6.8.1. Key Country Dynamics
8.6.8.2. Competitive Scenario
8.6.8.3. Regulatory Framework
8.6.8.4. Norway Market Estimates and Forecasts, 2018-2030
8.7. Asia-Pacific
8.7.1. Japan
8.7.1.1. Key Country Dynamics
8.7.1.2. Competitive Scenario
8.7.1.3. Regulatory Framework
8.7.1.4. Japan Market Estimates and Forecasts, 2018-2030
8.7.2. India
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. India Market Estimates and Forecasts, 2018-2030
8.7.3. China
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. China Market Estimates and Forecasts, 2018-2030
8.7.4. South Korea
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. South Korea Market Estimates and Forecasts, 2018-2030
8.7.5. Australia
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Australia Market Estimates and Forecasts, 2018-2030
8.7.6. Thailand
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Thailand Market Estimates and Forecasts, 2018-2030
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key Country Dynamics
8.8.1.2. Competitive Scenario
8.8.1.3. Regulatory Framework
8.8.1.4. Brazil Market Estimates and Forecasts, 2018-2030
8.8.2. Mexico
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Mexico Market Estimates and Forecasts, 2018-2030
8.8.3. Argentina
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Argentina Market Estimates and Forecasts, 2018-2030
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key Country Dynamics
8.9.1.2. Competitive Scenario
8.9.1.3. Regulatory Framework
8.9.1.4. South Africa Market Estimates and Forecasts, 2018-2030
8.9.2. Saudi Arabia
8.9.2.1. Key Country Dynamics
8.9.2.2. Competitive Scenario
8.9.2.3. Regulatory Framework
8.9.2.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030
8.9.3. UAE
8.9.3.1. Key Country Dynamics
8.9.3.2. Competitive Scenario
8.9.3.3. Regulatory Framework
8.9.3.4. UAE Market Estimates and Forecasts, 2018-2030
8.9.4. Kuwait
8.9.4.1. Key Country Dynamics
8.9.4.2. Competitive Scenario
8.9.4.3. Regulatory Framework
8.9.4.4. Kuwait Market Estimates and Forecasts, 2018-2030
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.4. Market Participant Categorization
9.4.1. List of Key Distributors and Channel Partners
9.4.2. Key Customers
9.4.3. Key Company Market Share Analysis, 2023
9.4.4. BioAgilytix Labs
9.4.4.1. Company Overview
9.4.4.2. Financial Performance
9.4.4.3. Service Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. KCAS Bioanalytical Services
9.4.5.1. Company Overview
9.4.5.2. Financial Performance
9.4.5.3. Service Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. IQVIA, Inc.
9.4.6.1. Company Overview
9.4.6.2. Financial Performance
9.4.6.3. Service Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Laboratory Corporation of America Holdings
9.4.7.1. Company Overview
9.4.7.2. Financial Performance
9.4.7.3. Service Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
9.4.8.1. Company Overview
9.4.8.2. Financial Performance
9.4.8.3. Service Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Prolytix
9.4.9.1. Company Overview
9.4.9.2. Financial Performance
9.4.9.3. Service Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Pharmaron
9.4.10.1. Company Overview
9.4.10.2. Financial Performance
9.4.10.3. Service Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Charles River Laboratories
9.4.11.1. Company Overview
9.4.11.2. Financial Performance
9.4.11.3. Service Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. Syneos Health
9.4.12.1. Company Overview
9.4.12.2. Financial Performance
9.4.12.3. Service Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. SGS SA
9.4.13.1. Company Overview
9.4.13.2. Financial Performance
9.4.13.3. Service Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. Intertek Group Plc
9.4.14.1. Company Overview
9.4.14.2. Financial Performance
9.4.14.3. Service Benchmarking
9.4.14.4. Strategic Initiatives
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.4. Market Participant Categorization
9.4.1. List of Key Distributors and Channel Partners
9.4.2. Key Customers
9.4.3. Key Company Market Share Analysis, 2023
9.4.4. BioAgilytix Labs
9.4.4.1. Company Overview
9.4.4.2. Financial Performance
9.4.4.3. Service Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. KCAS Bioanalytical Services
9.4.5.1. Company Overview
9.4.5.2. Financial Performance
9.4.5.3. Service Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. IQVIA, Inc.
9.4.6.1. Company Overview
9.4.6.2. Financial Performance
9.4.6.3. Service Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Laboratory Corporation of America Holdings
9.4.7.1. Company Overview
9.4.7.2. Financial Performance
9.4.7.3. Service Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
9.4.8.1. Company Overview
9.4.8.2. Financial Performance
9.4.8.3. Service Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Prolytix
9.4.9.1. Company Overview
9.4.9.2. Financial Performance
9.4.9.3. Service Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Pharmaron
9.4.10.1. Company Overview
9.4.10.2. Financial Performance
9.4.10.3. Service Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Charles River Laboratories
9.4.11.1. Company Overview
9.4.11.2. Financial Performance
9.4.11.3. Service Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. Syneos Health
9.4.12.1. Company Overview
9.4.12.2. Financial Performance
9.4.12.3. Service Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. SGS SA
9.4.13.1. Company Overview
9.4.13.2. Financial Performance
9.4.13.3. Service Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. Intertek Group Plc
9.4.14.1. Company Overview
9.4.14.2. Financial Performance
9.4.14.3. Service Benchmarking
9.4.14.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 4 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 5 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 6 North America Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 7 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 8 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 9 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 10 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 11 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 12 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 13 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 14 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 15 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 16 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 17 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 18 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 19 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 20 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 21 UK Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 22 UK Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 23 UK Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 24 UK Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 25 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 26 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 27 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 28 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 29 France Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 30 France Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 31 France Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 32 France Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 33 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 34 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 35 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 36 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 37 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 38 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 39 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 40 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 41 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 42 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 43 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 44 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 45 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 46 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 47 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 48 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 49 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 50 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 51 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 52 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 53 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 54 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 55 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 56 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 57 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 58 China Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 59 China Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 60 China Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 61 China Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 62 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 63 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 64 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 65 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 66 India Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 67 India Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 68 India Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 69 India Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 70 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 71 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 72 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 73 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 74 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 75 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 76 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 77 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 78 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 79 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 80 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 81 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 82 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 83 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 84 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 85 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 86 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 87 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 88 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 89 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 90 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 91 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 92 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 93 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 94 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 95 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 96 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 97 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 98 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 99 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 100 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 101 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 102 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 103 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 104 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 105 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 106 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 107 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 108 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 109 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 110 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 111 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 112 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 113 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 114 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 115 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 116 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 117 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 118 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 119 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 2 List of Abbreviations
Table 3 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 4 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 5 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 6 North America Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 7 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 8 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 9 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 10 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 11 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 12 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 13 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 14 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 15 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 16 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 17 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 18 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 19 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 20 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 21 UK Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 22 UK Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 23 UK Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 24 UK Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 25 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 26 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 27 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 28 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 29 France Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 30 France Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 31 France Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 32 France Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 33 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 34 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 35 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 36 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 37 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 38 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 39 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 40 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 41 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 42 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 43 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 44 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 45 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 46 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 47 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 48 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 49 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 50 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 51 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 52 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 53 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 54 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 55 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 56 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 57 Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 58 China Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 59 China Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 60 China Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 61 China Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 62 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 63 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 64 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 65 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 66 India Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 67 India Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 68 India Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 69 India Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 70 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 71 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 72 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 73 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 74 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 75 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 76 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 77 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 78 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 79 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 80 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 81 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 82 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 83 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 84 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 85 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 86 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 87 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 88 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 89 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 90 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 91 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 92 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 93 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 94 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 95 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 96 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 97 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 98 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 99 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Region, 2018-2030 (USD Million)
Table 100 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 101 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 102 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 103 Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 104 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 105 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 106 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 107 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 108 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 109 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 110 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 111 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 112 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 113 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 114 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 115 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
Table 116 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018-2030 (USD Million)
Table 117 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018-2030 (USD Million)
Table 118 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of Development by Product Type, 2018-2030 (USD Million)
Table 119 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews in North America
Figure 5 Primary Interviews in Europe
Figure 6 Primary Interviews in APAC
Figure 7 Primary Interviews in Latin America
Figure 8 Primary Interviews in MEA
Figure 9 Market Research Approaches
Figure 10 Value-chain-based Sizing & Forecasting
Figure 11 QFD Modeling for Market Share Assessment
Figure 12 Market Formulation & Validation
Figure 13 Market Snapshot
Figure 14 Segment Snapshot
Figure 15 Competitive Landscape Snapshot
Figure 16 Parent Market Outlook
Figure 17 Related/ancillary Market Outlook
Figure 18 Cell & Gene Therapy Bioanalytical Testing Services Market - Industry Value Chain Analysis
Figure 19 Cell & Gene Therapy Bioanalytical Testing Services Market Driver Analysis
Figure 20 Cell & Gene Therapy Bioanalytical Testing Services Market Restraint Analysis
Figure 21 Cell & Gene Therapy Bioanalytical Testing Services Market: Porter's Analysis
Figure 22 Cell & Gene Therapy Bioanalytical Testing Services Market: PESTLE Analysis
Figure 23 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Outlook and Key Takeaways
Figure 24 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Market Share Analysis, 2023-2030
Figure 25 Bioavailability & Bioequivalence Studies Market, 2018-2030 (USD Million)
Figure 26 Pharmacokinetics Market, 2018-2030 (USD Million)
Figure 27 Pharmacodynamics Market, 2018-2030 (USD Million)
Figure 28 Other Test Type Market, 2018-2030 (USD Million)
Figure 29 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Outlook and Key Takeaways
Figure 30 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Market Share Analysis, 2023-2030
Figure 31 Gene Therapy Market, 2018-2030 (USD Million)
Figure 32 Ex-vivo Market, 2018-2030 (USD Million)
Figure 33 in-vivo Market, 2018-2030 (USD Million)
Figure 34 Gene-Modified Cell Therapy Market, 2018-2030 (USD Million)
Figure 35 CAR T-Cell Therapies Market, 2018-2030 (USD Million)
Figure 36 CAR-NK Cell Therapy Market, 2018-2030 (USD Million)
Figure 37 TCR-T Cell Therapy Market, 2018-2030 (USD Million)
Figure 38 Other Market, 2018-2030 (USD Million)
Figure 39 Cell Therapy Market, 2018-2030 (USD Million)
Figure 40 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type Outlook and Key Takeaways
Figure 41 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type Market Share Analysis, 2023-2030
Figure 42 Non-clinical Market, 2018-2030 (USD Million)
Figure 43 Gene Therapy Market, 2018-2030 (USD Million)
Figure 44 Gene-modified Cell Therapy Market, 2018-2030 (USD Million)
Figure 45 Cell Therapy Market, 2018-2030 (USD Million)
Figure 46 Clinical Market, 2018-2030 (USD Million)
Figure 47 Gene Therapy Market, 2018-2030 (USD Million)
Figure 48 Gene-modified Cell Therapy Market, 2018-2030 (USD Million)
Figure 49 Cell Therapy Market, 2018-2030 (USD Million)
Figure 50 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Outlook and Key Takeaways
Figure 51 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Market Share Analysis, 2023-2030
Figure 52 Oncology Market, 2018-2030 (USD Million)
Figure 53 Infectious Diseases Market, 2018-2030 (USD Million)
Figure 54 Neurological Disorders Market, 2018-2030 (USD Million)
Figure 55 Rare Diseases Market, 2018-2030 (USD Million)
Figure 56 Others Market, 2018-2030 (USD Million)
Figure 57 Regional Marketplace: Key Takeaways
Figure 58 Regional Marketplace: Key Takeaways
Figure 59 North America Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 60 U.S. Key Country Dynamics
Figure 61 U.S. Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 62 Canada Key Country Dynamics
Figure 63 Canada Market, 2018-2030 (USD Million)
Figure 64 Europe Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 65 Germany Key Country Dynamics
Figure 66 Germany Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 67 UK Key Country Dynamics
Figure 68 UK Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 69 France Key Country Dynamics
Figure 70 France Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 71 Italy Key Country Dynamics
Figure 72 Italy Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 73 Spain Key Country Dynamics
Figure 74 Spain Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 75 Denmark Key Country Dynamics
Figure 76 Denmark Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 77 Sweden Key Country Dynamics
Figure 78 Sweden Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 79 Norway Key Country Dynamics
Figure 80 Norway Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 81 Asia-Pacific Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 82 Japan Key Country Dynamics
Figure 83 Japan Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 84 China Key Country Dynamics
Figure 85 China Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 86 India Key Country Dynamics
Figure 87 India Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 88 Australia Key Country Dynamics
Figure 89 Australia Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 90 Thailand Key Country Dynamics
Figure 91 Thailand Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 92 South Korea Key Country Dynamics
Figure 93 South Korea Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 94 Latin America Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 95 Brazil Key Country Dynamics
Figure 96 Brazil Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 97 Mexico Key Country Dynamics
Figure 98 Mexico Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 99 Argentina Key Country Dynamics
Figure 100 Argentina Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 101 MEA Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 102 South Africa Key Country Dynamics
Figure 103 South Africa Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 104 Saudi Arabia Key Country Dynamics
Figure 105 Saudi Arabia Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 106 UAE Key Country Dynamics
Figure 107 UAE Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 108 Kuwait Key Country Dynamics
Figure 109 Kuwait Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 110 Key Company Categorization
Figure 111 Company Market Positioning
Figure 112 Market Participant Categorization
Figure 113 Strategy Framework
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews in North America
Figure 5 Primary Interviews in Europe
Figure 6 Primary Interviews in APAC
Figure 7 Primary Interviews in Latin America
Figure 8 Primary Interviews in MEA
Figure 9 Market Research Approaches
Figure 10 Value-chain-based Sizing & Forecasting
Figure 11 QFD Modeling for Market Share Assessment
Figure 12 Market Formulation & Validation
Figure 13 Market Snapshot
Figure 14 Segment Snapshot
Figure 15 Competitive Landscape Snapshot
Figure 16 Parent Market Outlook
Figure 17 Related/ancillary Market Outlook
Figure 18 Cell & Gene Therapy Bioanalytical Testing Services Market - Industry Value Chain Analysis
Figure 19 Cell & Gene Therapy Bioanalytical Testing Services Market Driver Analysis
Figure 20 Cell & Gene Therapy Bioanalytical Testing Services Market Restraint Analysis
Figure 21 Cell & Gene Therapy Bioanalytical Testing Services Market: Porter's Analysis
Figure 22 Cell & Gene Therapy Bioanalytical Testing Services Market: PESTLE Analysis
Figure 23 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Outlook and Key Takeaways
Figure 24 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Market Share Analysis, 2023-2030
Figure 25 Bioavailability & Bioequivalence Studies Market, 2018-2030 (USD Million)
Figure 26 Pharmacokinetics Market, 2018-2030 (USD Million)
Figure 27 Pharmacodynamics Market, 2018-2030 (USD Million)
Figure 28 Other Test Type Market, 2018-2030 (USD Million)
Figure 29 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Outlook and Key Takeaways
Figure 30 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Market Share Analysis, 2023-2030
Figure 31 Gene Therapy Market, 2018-2030 (USD Million)
Figure 32 Ex-vivo Market, 2018-2030 (USD Million)
Figure 33 in-vivo Market, 2018-2030 (USD Million)
Figure 34 Gene-Modified Cell Therapy Market, 2018-2030 (USD Million)
Figure 35 CAR T-Cell Therapies Market, 2018-2030 (USD Million)
Figure 36 CAR-NK Cell Therapy Market, 2018-2030 (USD Million)
Figure 37 TCR-T Cell Therapy Market, 2018-2030 (USD Million)
Figure 38 Other Market, 2018-2030 (USD Million)
Figure 39 Cell Therapy Market, 2018-2030 (USD Million)
Figure 40 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type Outlook and Key Takeaways
Figure 41 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type Market Share Analysis, 2023-2030
Figure 42 Non-clinical Market, 2018-2030 (USD Million)
Figure 43 Gene Therapy Market, 2018-2030 (USD Million)
Figure 44 Gene-modified Cell Therapy Market, 2018-2030 (USD Million)
Figure 45 Cell Therapy Market, 2018-2030 (USD Million)
Figure 46 Clinical Market, 2018-2030 (USD Million)
Figure 47 Gene Therapy Market, 2018-2030 (USD Million)
Figure 48 Gene-modified Cell Therapy Market, 2018-2030 (USD Million)
Figure 49 Cell Therapy Market, 2018-2030 (USD Million)
Figure 50 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Outlook and Key Takeaways
Figure 51 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Market Share Analysis, 2023-2030
Figure 52 Oncology Market, 2018-2030 (USD Million)
Figure 53 Infectious Diseases Market, 2018-2030 (USD Million)
Figure 54 Neurological Disorders Market, 2018-2030 (USD Million)
Figure 55 Rare Diseases Market, 2018-2030 (USD Million)
Figure 56 Others Market, 2018-2030 (USD Million)
Figure 57 Regional Marketplace: Key Takeaways
Figure 58 Regional Marketplace: Key Takeaways
Figure 59 North America Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 60 U.S. Key Country Dynamics
Figure 61 U.S. Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 62 Canada Key Country Dynamics
Figure 63 Canada Market, 2018-2030 (USD Million)
Figure 64 Europe Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 65 Germany Key Country Dynamics
Figure 66 Germany Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 67 UK Key Country Dynamics
Figure 68 UK Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 69 France Key Country Dynamics
Figure 70 France Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 71 Italy Key Country Dynamics
Figure 72 Italy Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 73 Spain Key Country Dynamics
Figure 74 Spain Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 75 Denmark Key Country Dynamics
Figure 76 Denmark Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 77 Sweden Key Country Dynamics
Figure 78 Sweden Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 79 Norway Key Country Dynamics
Figure 80 Norway Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 81 Asia-Pacific Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 82 Japan Key Country Dynamics
Figure 83 Japan Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 84 China Key Country Dynamics
Figure 85 China Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 86 India Key Country Dynamics
Figure 87 India Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 88 Australia Key Country Dynamics
Figure 89 Australia Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 90 Thailand Key Country Dynamics
Figure 91 Thailand Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 92 South Korea Key Country Dynamics
Figure 93 South Korea Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 94 Latin America Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 95 Brazil Key Country Dynamics
Figure 96 Brazil Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 97 Mexico Key Country Dynamics
Figure 98 Mexico Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 99 Argentina Key Country Dynamics
Figure 100 Argentina Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 101 MEA Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 102 South Africa Key Country Dynamics
Figure 103 South Africa Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 104 Saudi Arabia Key Country Dynamics
Figure 105 Saudi Arabia Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 106 UAE Key Country Dynamics
Figure 107 UAE Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 108 Kuwait Key Country Dynamics
Figure 109 Kuwait Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 110 Key Company Categorization
Figure 111 Company Market Positioning
Figure 112 Market Participant Categorization
Figure 113 Strategy Framework
Companies Mentioned
- BioAgilytix Labs
- KCAS Bioanalytical Services
- IQVIA, Inc.
- Laboratory Corporation of America Holdings
- Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
- Prolytix
- Pharmaron
- Charles River Laboratories
- Syneos Health
- SGS SA
- Intertek Group Plc
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 261 |
| Published | May 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 506.1 Million |
| Forecasted Market Value ( USD | $ 828.7 Million |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
